Back to FULC

Fulcrum Therapeutics, Inc. 8-K

Accession 0000950170-23-021958

Filing information

CIK
0001680581
Report date
2023-05-11
Filing date
2023-05-15
Form
8-K
Primary document
fulc-20230511.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.